Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bruinsma

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
International Journal of Dermatology|April 1, 1986
Drug monitoring in dermatologyW Bruinsma
Dermatologica|January 1, 1972
Adverse reaction profiles of drug eruptionsW Bruinsma
Nederlands Tijdschrift Voor Geneeskunde|February 26, 1972
[Goals and properties of the Bureau of Drug Control]W Bruinsma
Nederlands Tijdschrift Voor Geneeskunde|September 16, 1972
[Evaluation of rare side effects]W Bruinsma
Seminars in Dermatology|September 1, 1989
The file of side effects to the skin: a guide to drug eruptionsW Bruinsma
Annals of Clinical Research|March 1, 1970
Exchange autografts of skin in lupus erythematosusR H Cormane, W Bruinsma
Carcinogenesis|September 5, 2007
The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferationHye Jin You, Monique W Bruinsma, Tam How, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 18, 2022
Does placental abruption cause neonatal anemia?Marieke A W Bruinsma, Marjon A de Boer, Sandra Prins, et al.
Oncogene|October 11, 2016
Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by BoraW Bruinsma, M Aprelia, I García-Santisteban, et al.
The Journal of Biological Chemistry|January 11, 2008
Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptorKellye C Kirkbride, Todd A Townsend, Monique W Bruinsma, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
International Journal of Dermatology|April 1, 1986
Drug monitoring in dermatologyW Bruinsma
Dermatologica|January 1, 1972
Adverse reaction profiles of drug eruptionsW Bruinsma
Nederlands Tijdschrift Voor Geneeskunde|February 26, 1972
[Goals and properties of the Bureau of Drug Control]W Bruinsma
Nederlands Tijdschrift Voor Geneeskunde|September 16, 1972
[Evaluation of rare side effects]W Bruinsma
Seminars in Dermatology|September 1, 1989
The file of side effects to the skin: a guide to drug eruptionsW Bruinsma
Annals of Clinical Research|March 1, 1970
Exchange autografts of skin in lupus erythematosusR H Cormane, W Bruinsma
Carcinogenesis|September 5, 2007
The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferationHye Jin You, Monique W Bruinsma, Tam How, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 18, 2022
Does placental abruption cause neonatal anemia?Marieke A W Bruinsma, Marjon A de Boer, Sandra Prins, et al.
Oncogene|October 11, 2016
Inhibition of Polo-like kinase 1 during the DNA damage response is mediated through loss of Aurora A recruitment by BoraW Bruinsma, M Aprelia, I García-Santisteban, et al.
The Journal of Biological Chemistry|January 11, 2008
Bone morphogenetic proteins signal through the transforming growth factor-beta type III receptorKellye C Kirkbride, Todd A Townsend, Monique W Bruinsma, et al.
Pageof 2